Fusiform, Inc. (www.fusiform.co), which is radically rethinking the billion-dollar orthopedic industry, is proud to announce Doug McCormack, a veteran of similar health care companies, is joining Fusiform’s board of advisors.

McCormack’s experience in the field runs deep. He was a founder/co-founder of two venture-backed companies, Orthocare Innovations and Modus Health. Prior to his early-stage company focus, he spent 15 years as a health and health policy lawyer and advocate in Washington, D.C., advising health care companies, associations and organizations, including many of the leading players in the orthotic and prosthetic field. This combined experience has positioned him well to understand the opportunities that exist for disruption in the sector.

“Fusiform has developed a system to improve the processes of patient fitting and device fabrication as more and more providers rely on central fabrication—something that is absolutely ripe for improvement. Their vision is ready for scalability. Fusiform has a perfect combination of technology, industry know-how and cost savings to make a difference,” says McCormack.

Fusiform is currently finishing its successful seed round of funding. It focuses on orthopedic devices that are externally worn braces that modify and correct the growth of the musculoskeletal system (feet, legs and spine). Traditionally, they are made by hand in a time-consuming manner.

Fusiform has implemented a dynamic order management platform that allows specialists to securely and efficiently fulfill these orders. Rather than cast a patient using plaster, Fusiform has developed a way for specialists to take a 3D scan of the area of the body that needs to be corrected, upload that scan to FusiformCAST and seamlessly direct the order to a device fabricator. This means specialists, including more than a dozen using Fusiform right now, can see more patients and improve order accuracy.

“We are honored Doug is joining our board of advisors. His experience both as an entrepreneur and advisor is well-recognized in our industry, and we will benefit from his insights,” says Param Shah, co-founder and CEO, Fusiform.

McCormack, who was named by Fierce Medical Devices to the “Fierce 15 Medical Device CEOs to Watch in 2013,” joins Fusiform’s advisory board, whose members include Harry Goldberg, Ph.D., assistant dean, Johns Hopkins School of Medicine; Paul Grossinger, founder, Blue Jay Syndicate; Peter Raymond, CEO, Human Condition; and David Wise, CEO, Pharos Biologicals.